Donald Lloyd-Jones, MD

Professor, Boston University Chobanian & Avedisian School of Medicine

Biography

Dr. Lloyd-Jones’ research interests include the study of the mechanisms and life course of cardiovascular health and healthy aging, and cardiovascular disease epidemiology, risk estimation and prevention. Other areas of interest include the use of novel biomarkers and imaging of subclinical atherosclerosis to improve prevention, and the epidemiology and outcomes of hypertension and dyslipidemia. His clinical and teaching interests lie in general cardiology, with a focus on prevention.

He also has been a national leader in public health and clinical approaches to promoting cardiovascular health and preventing cardiovascular diseases across the life course. He served as co-chair of the Risk Assessment Guidelines and a member of the Cholesterol Treatment Guidelines Panel for the 2013 ACC/AHA Guidelines for Cardiovascular Disease Risk Reduction; and was the lead member for risk assessment on the 2018 Cholesterol Guidelines Panel and the 2019 Primary Prevention Guidelines Panel. He has authored over 750 peer-reviewed scientific publications and has been a PI or co-investigator on more than 120 grants (the vast majority from NIH)

Publications

  • Published 5/14/2025

    Lam EL, Gauen AM, Kandula NR, Notterman DA, Goldman N, Lloyd-Jones DM, Allen NB, Shah NS. Early Childhood Food Insecurity and Cardiovascular Health in Young Adulthood. JAMA Cardiol. 2025 May 14. PMID: 40366649.

    Read at: PubMed

  • Published 5/7/2025

    Goldman N, Allen NB, Pratt B, Ning H, Schneper L, Lloyd-Jones D, Notterman D. Racial and Ethnic Variation in Socioeconomic Differentials in Young Adult Cardiovascular Health. Am J Epidemiol. 2025 May 07. PMID: 40331753.

    Read at: PubMed

  • Published 5/5/2025

    Philbin SE, Gleason LP, Persell SD, Walter E, Petito LC, Tibrewala A, Yancy CW, Beidas RS, Wilcox JE, Mutharasan RK, Lloyd-Jones D, O'Brien MJ, Kho AN, McHugh MC, Smith JD, Ahmad FS. Barriers and Facilitators to Heart Failure Guideline-Directed Medical Therapy in an Integrated Health System and Federally Qualified Health Centers: A Thematic Qualitative Analysis. J Gen Intern Med. 2025 May 05. PMID: 40325339.

    Read at: PubMed

  • Published 5/1/2025

    Freaney PM, Huang X, Petito LC, Grobman WA, Catov J, Hauspurg A, Bairey Merz CN, Bello N, Kim JK, Lane A, Haas DM, Levine LD, McNeil RB, Miller E, Saade G, Theilen L, Yee LM, Varagic J, Mercer B, Reddy U, Lloyd-Jones DM, Greenland P, Khan SS. Adverse Pregnancy Outcomes and N-Terminal Pro-Brain Natriuretic Peptide Levels 2 to 7 Years After Delivery: The nuMoM2b Heart Health Study. JAMA Cardiol. 2025 May 01; 10(5):514-516. PMID: 40172904.

    Read at: PubMed

  • Published 4/29/2025

    Razavi AC, Troy AL, Patel J, Mehta LS, Spitz JA, Lloyd-Jones D, Whelton SP, Johansen MC, Blumenthal RS. Future of Stroke Prevention: 7 Updates in the 2024 AHA/ASA Primary Prevention of Stroke Guideline. JACC Adv. 2025 Apr 29; 101724. PMID: 40338758.

    Read at: PubMed

Other Positions

  • Director of Framingham Center for Population and Prevention Science, Framingham Heart Study
    Boston University
  • Principal Investigator of the Framingham Heart Study, Framingham Heart Study
    Boston University
  • Chief of the section, Preventive Medicine
    Boston University

Education

  • Columbia University College of Physicians and Surgeons, MD
  • Harvard School of Public Health, MS
  • Swarthmore College, BA